Clinical Trial Update: Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing sirolimus plus mycophenolate mofetil to tacrolimus plus mycophenolate mofetil in kidney transplant recipients has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• CELLCEPT (mycophenolate mofetil hydrochloride)
• Rapamune (sirolimus)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Kidney Transplantation | Phase 3 | Status: TERMINATED